Pefrilo 40 mg, 10 mg Oral Granules
PDF Leaflet Revision Date: 26 September 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV-1 infection in adults and children over 6 months.
Dosage (summary)
Adults: 400/100 mg twice daily; Children: 3-6 sachets twice daily based on weight.
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy; avoid breastfeeding.
Key Drug Interactions
- CYP3A4 substrates
- Rifampicin
- Colchicine
Contraindications
- Severe hepatic impairment
- Hypersensitivity to components
Common side effects
- Diarrhoea
- Nausea
- Vomiting
- Dyslipidaemia
Counselling Points
- Take with food
- Monitor for liver function
- Avoid certain medications
Serious warnings
- Risk of pancreatitis
- Increased bleeding in haemophilia
- Immune reactivation syndrome
Important Disclaimer
The Pefrilo 40 mg, 10 mg Oral Granules professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
